Skip to content

{ Tag Archives } Serious Skin

European Medicines Agency Confirms Positive Benefit-Risk Balance Of Topical Formulations Of Ketoprofen

Main Category: Dermatology
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 23 Jul 2010 – 1:00 PDT

email to a friend   printer friendly   view / write opinions
<!–   rate article

Following a review of topical formulations of ketoprofen, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , ,

Creating Beauty Out of Bargain Mineral Makeup

New Treatment For Psoriasis
Make up have been there for ages. These have been utilized by both adults for various purposes. Although these are more known to be used for vanity, some individuals who have serious skin disorders seek without the aid of makeup to conceal such dilemma. It’s not important whether you can simply afford [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , , ,

Regulatory Science Update: FDA And International Serious Adverse Events Consortium Complete Third Data Release

The U.S. Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC) announced the third release of data on the genetic basis of drug-induced liver injury (DILI) and serious skin reactions (SSRs). The data focus on the genetics associated with DILI and SSR and may help researchers to better predict an individual’s [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , ,

Tibotec, FDA Update Warning Label On HIV Drug’s Risk Of Severe Skin Reaction

Tibotec Therapeutics, a unit of Johnson & Johnson, “has strengthened a warning about serious skin reactions in patients treated with the company’s HIV drug Intelence,” the FDA and the company said on Wednesday, Reuters reports.

Bookmark and Share Also tagged , , , , , , , ,

FDA And International Serious Adverse Events Consortium Release First Data On Genetic Basis Of Adverse Drug Events

The first data offering health care professionals a better look into the genetic basis of certain types of adverse drug events was released today by the FDA and the International Serious Adverse Event Consortium (SAEC). The data are focused on the genetics associated with drug-induced serious skin rashes, such as Stevens-Johnson syndrome and toxic epidermal [...]

Bookmark and Share Also tagged , , , , , , , , , , ,